Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mat-A-Cell is a biotechnology company spun off from Hong Kong Baptist University that specializes in nanostructure-based medical devices for stem cell differentiation. The company's core technology, Mat A® Culture Nanomatrices, provides an extracellular environment that facilitates the transformation of stem cells into functional cells, such as neurons, without the risk of carcinogenicity or inflammation. This platform is designed to support the development of safer stem cell therapies for incurable diseases, including Parkinson's and other neurological disorders. Mat-A-Cell operates in Hong Kong and has expanded its presence into Mainland China through a subsidiary in Guangzhou. The company's innovations have been recognized with multiple international awards, including a Gold Medal at the International Exhibition of Inventions of Geneva.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mat-A-Cell.